Opioid MOP receptor agonists in late-stage development for the treatment of postoperative pain. (PubMed, Expert Opin Pharmacother) - Oct 28, 2022 - ": Oliceridine appears to be an effective and potentially safer μ opioid receptor agonist...Cebranopadol is an agonist at multiple opioid receptors, of which μ opioid and nociceptin/orphanin FQ peptide (NOP) receptor are most significant...Lastly, morphine-6-glucuronide is an active metabolite of morphine with a slower onset than its parent compound. It has failed to demonstrate appreciable benefit in the context of postoperative analgesia."
Journal • CNS Disorders • Depression • Neuralgia • Pain • Psychiatry
|